The extent of lipoprotein glycation was assessed in 82 patients diagnosed as diabetes mellitus type II. Glycated lipoprotein levels in serum were determined by agarose gel film electrophoresis in 48 non-diabetic control subjects, 56 diabetics with complications and 26 diabetics with no complications. All glycated lipoproteins were higher in the patients when the diabetics were compared to the control group, but glycated very low-density lipoprotein (VLDL) was the only glycated lipoprotein fraction that was observed to be higher in the diabetic patients with complications compared to the patients without complications (P < 0·01). Triglycerides and VLDL-cholesterol were also increased in the diabetics, but there was no significant difference in these variables when the patients without complications were compared to the control subjects. There was no difference in total cholesterol and low-density lipoprotein (LDL)-cholesterol levels of the diabetic patients compared to the controls.
CurtissLKWitztumJL. Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes1985; 34: 452–61.
2.
The DCCT Research Group. Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. Diabet Care1992; 15: 886–94.
3.
Lopes-VirellaMFKleinRLLyonsTJStevensonHCWitztumJL. Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes1988; 37: 550–7.
4.
LyonsTJKleinRLBaynesJWStevensonHCLopes-VirellaMF. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: The influence of non-enzymatic glycosylation of low-density lipoproteins. Diabetologia1987; 30: 916–23.
5.
LyonsTJBaynesJWPatrickJSColwellJALopes-VirellaMF. Glycosylation of low density lipoprotein in patients with Type 1 (insulin-dependent) diabetes: Correlations with other parameters of glycaemic control. Diabetologia1986; 29: 685–9.
6.
GinsbergHN. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care1991; 14: 839–55.
7.
MamoJCLSzetoLSteinerG.Glycation of very low density lipoprotein from rat plasma impairs its catabolism. Diabetologia1990; 33: 339–45.
8.
KobayashiKOgasaharaNSakoguchiTKimuraMTaniuchiKMatsuokaA.Agarose gel electrophoresis with nitrobluetetrazolium coloration for determination of glycated lipoproteins in serum from diabetics. Clin Chem1990; 36: 65–9.
9.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes1979; 28: 1039–57.
10.
BakerJRMetcalfPAJohnsonRNNewmanDRietzP.Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem1985; 31: 1550–4.
11.
SteinEA. Lipids, lipoproteins, and apolipoproteins. In: TietzNW, ed. Textbook of Clinical Chemistry. Philadelphia: WB Saunders Company, 1986: 873–85.
12.
RifaiNWarnickGRMcNamaraJRBelcherJDGrinsteadGFFrantzID. Measurement of low-density-lipoprotein cholesterol in serum: A status report. Clin Chem1992; 38: 150–60.
13.
WitztumJLMahoneyEMBranksMJFisherMElamRSteinbergD.Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes1982; 31: 283–91.
14.
PratJPamplonaRSorribasAMartinSVinallongaMSeguraR.Correlation of plasma lipid fractions with colorimetrically determined glycated hemoglobin in a nondiabetic population. Metabolism1989; 38: 1147–53.
15.
RönnemaaTLaaksoMKallioVPyöralaKMarniemiJPuukkaP.Serum lipids, lipoproteins, and apolipoproteins and the excessive occurence of coronary heart disease in non-insulin-dependent diabetic patients. Am J Epidemiol1989; 130: 632–45.
16.
WinocourPHDurringtonPNIsholaMHillierVFAndersonDC. The prevalence of hyperlipidaemia and related clinical features in insulin-dependent diabetes mellitus. Q J Med1989; 70: 265–76.
17.
LaaksoMPyöralaK.Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease. Atherosclerosis1988; 74: 55–63.
18.
BrionesERMaoSJTPalumboPJO'FallonWMChenowethWKottkeBA. Analysis of plasma lipids and lipoproteins in insulin-dependent and non-insulin-dependent diabetics. Metabolism1984; 33: 42–9.
19.
LaaksoMBarrett-ConnorE.Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis1989; 9: 665–72.
20.
LaaksoMVoutilainenESarlundHAroAPyöralaKPenttilaI.Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics. Atherosclerosis1985; 56: 271–81.
21.
MagnatiGArsenioLBaroniMCBodriaPBossiSDelsignoreRComparison of HbA1c, fructosamine and the main metabolic parameters in a non-insulin-dependent diabetic population [Italian]. G Clin Med1990; 71: 25–30.
22.
WillemsDDorchyH.Lipoprotein and apolipoprotein levels in young insulin-dependent diabetic patients. Relations with glycosylated hemoglobin and fructosamine. [French]. Presse Med1990; 19: 17–20.
23.
ManciniMPauciulloPCorteseCRubbaPRiccardiGRivelleseA.Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes. Horm Metab Res1988; 19 (Suppl): 13–15.
